Financial PerformanceQuipt reported solid results that beat expectations as it continues to execute operationally, demonstrated by its strong growth and Adjusted EBITDA margin expansion.
New Product OfferingThe company announced that it will begin offering diabetes products, such as continuous glucose monitors, to drive growth longer-term.
Share Repurchase ProgramA share repurchase program of up to 10% of the public float was announced, viewed as a logical use of capital given its depressed valuation.